Obsidian Therapeutics, Inc. (OBX)

NASDAQ: OBX · Real-Time Price · USD

35.00

+7.50 (27.27%)

At close: Aug 10, 2026, 4:00 PM EDT

35.70

+0.70 (2.00%)

After-hours: Aug 10, 2026, 6:18 PM EDT

Obsidian Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	18.63	19.55	18.07
Research & Development	80.72	86.11	73.19
Operating Expenses	99.34	105.67	91.26
Operating Income	-99.34	-105.67	-91.26
Interest & Investment Income	4.09	5.06	8.15
Pretax Income	-95.25	-100.61	-83.11
Net Income	-95.25	-100.61	-83.11
Net Income to Common	-95.25	-100.61	-83.11
Net Income Growth	-	-	-
Shares Outstanding (Basic)	0	0	-
Shares Outstanding (Diluted)	0	0	-
Shares Change	-	-	-
EPS (Basic)	-1287.13	-2056.18	-
EPS (Diluted)	-1287.13	-2056.18	-
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-88.06	-90.47	-75.78
Free Cash Flow Per Share	-1189.85	-1848.92	-
EBITDA	-97.9	-104.18	-89.73
D&A For EBITDA	1.45	1.48	1.53
EBIT	-99.34	-105.67	-91.26

SEC Filings: 10-K · 10-Q